实用医学杂志2025，Vol.41Issue(5)：766-772,7.DOI:10.3969/j.issn.1006-5725.2025.05.022
肿瘤相关静脉血栓栓塞症防治基石
Research progress on role of anticoagulant drugs in prevention and treatment of cancer-associated venous thromboembolism
摘要
Abstract
Cancer-associated venous thromboembolism(CAT)refers to the presence of venous thromboem-bolism including deep vein thrombosis and pulmonary embolism in patients with malignant cancer.Studies have indicated that CAT has become the second leading cause of death among cancer patients.Similar to other methods used to prevent and treat venous thromboembolism,anticoagulation remains to be the primary approach for CAT.However,the occurrence of CAT is influenced by various factors such as tumor type,staging,complications,treat-ment,and prognosis.This complexity makes the prevention and management of CAT more difficult and challeng-ing.This article reviews the classification of commonly used anticoagulant drugs in clinical practice,emphasizing the current status and advancements in their application for the prevention and treatment of cancer-related venous thromboembolism in order to provide valuable reference for clinical medication.关键词
肿瘤相关静脉血栓栓塞症/抗凝药/肝素/低分子肝素/新型抗凝药Key words
cancer-associated venous thromboembolism/anticoagulant drugs/heparin/low molecu-lar weight heparin/new anticoagulants分类
医药卫生引用本文复制引用
秦小莉,高秀容,何琴,骆竹媚,蒋倩..肿瘤相关静脉血栓栓塞症防治基石[J].实用医学杂志,2025,41(5):766-772,7.基金项目
国家自然科学基金青年基金项目(编号:72204039) （编号:72204039）
四川省自然科学基金项目(编号:23NSFSC4722) （编号:23NSFSC4722）
